Literature DB >> 18181712

The safety of probiotics.

David R Snydman1.   

Abstract

Probiotics are generally defined as microorganisms that, when consumed, generally confer a health benefit on humans. There is considerable interest in probiotics for a variety of medical conditions, and millions of people around the world consume probiotics daily for perceived health benefits. Lactobacilli, bifidobacteria, and lactococci have generally been regarded as safe. There are 3 theoretical concerns regarding the safety of probiotics: (1) the occurrence of disease, such as bacteremia or endocarditis; (2) toxic or metabolic effects on the gastrointestinal tract; and (3) the transfer of antibiotic resistance in the gastrointestinal flora. In this review, the evidence for safety of the use of or the study of probiotics is examined. Although there are rare cases of bacteremia or fungemia related to the use of probiotics, epidemiologic evidence suggests no population increase in risk on the basis of usage data. There have been many controlled clinical trials on the use of probiotics that demonstrate safe use. The use of probiotics in clinical trials should be accompanied by the use of a data-safety monitoring board and by knowledge of the antimicrobial susceptibilities of the organism used.

Entities:  

Mesh:

Year:  2008        PMID: 18181712     DOI: 10.1086/523331

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  69 in total

Review 1.  A gastroenterologist's guide to probiotics.

Authors:  Matthew A Ciorba
Journal:  Clin Gastroenterol Hepatol       Date:  2012-04-10       Impact factor: 11.382

2.  Screening and evaluation of human intestinal lactobacilli for the development of novel gastrointestinal probiotics.

Authors:  Piret Kõll; Reet Mändar; Imbi Smidt; Pirje Hütt; Kai Truusalu; Raik-Hiio Mikelsaar; Jelena Shchepetova; Kasper Krogh-Andersen; Harold Marcotte; Lennart Hammarström; Marika Mikelsaar
Journal:  Curr Microbiol       Date:  2010-05-05       Impact factor: 2.188

Review 3.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

Review 4.  Probiotics, enteric and diarrheal diseases, and global health.

Authors:  Geoffrey A Preidis; Colin Hill; Richard L Guerrant; B S Ramakrishna; Gerald W Tannock; James Versalovic
Journal:  Gastroenterology       Date:  2010-11-12       Impact factor: 22.682

5.  Lactobacillus acidophilus Restores Functionality in Uremic Macrophages: Plausible or Lacking Evidence?

Authors:  Luis Vitetta
Journal:  Dig Dis Sci       Date:  2016-06       Impact factor: 3.199

Review 6.  Probiotics and liver disease.

Authors:  Vishal Sharma; Shashank Garg; Sourabh Aggarwal
Journal:  Perm J       Date:  2013

Review 7.  A potential role of probiotics in colorectal cancer prevention: review of possible mechanisms of action.

Authors:  Esther Swee Lan Chong
Journal:  World J Microbiol Biotechnol       Date:  2013-09-26       Impact factor: 3.312

Review 8.  Travellers' diarrhoea - pros and cons of different prophylactic measures.

Authors:  Angelika Wagner; Ursula Wiedermann
Journal:  Wien Klin Wochenschr       Date:  2009-10       Impact factor: 1.704

9.  Are probiotics safe for use during pregnancy and lactation?

Authors:  Jackie Elias; Pina Bozzo; Adrienne Einarson
Journal:  Can Fam Physician       Date:  2011-03       Impact factor: 3.275

Review 10.  Probiotics: progress toward novel therapies for intestinal diseases.

Authors:  Fang Yan; David Brent Polk
Journal:  Curr Opin Gastroenterol       Date:  2010-03       Impact factor: 3.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.